Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

about

Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.

P2860

Q36435773-D87E6852-F76D-43FD-8D5C-E82484F63A58 Q39835731-8CAE95F4-A58B-48B0-A18C-1C08252632B0

P2860

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

Item

http://www.wikidata.org/entity/Q35740465

description

1983 nî lūn-bûn

@nan

1983年の論文

@ja

1983年論文

@yue

1983年論文

@zh-hant

1983年論文

@zh-hk

1983年論文

@zh-mo

1983年論文

@zh-tw

1983年论文

@wuu

1983年论文

@zh

1983年论文

@zh-cn

name

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@ast

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@en

type

Item

label

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@ast

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@en

prefLabel

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@ast

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@en

P1476

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

@en

P2093

D H Ellis

http://www.w3.org/2001/XMLSchema#string

G P Bodey

http://www.w3.org/2001/XMLSchema#string

P Salvador

http://www.w3.org/2001/XMLSchema#string

R E Weinfeld

http://www.w3.org/2001/XMLSchema#string

R G Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents

In vitro evaluation of Ro 13-9904

Pharmacokinetics of ceftriaxone in humans.

Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.

Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

The role of schedule of antibiotic therapy on the neutropenic patient.

P304

583-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.23.4.583

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1983-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6305263

http://www.w3.org/2001/XMLSchema#string

P932

184705

http://www.w3.org/2001/XMLSchema#string

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

about

P2860

P2860

Clinical pharmacology of ceftriaxone in patients with neoplastic disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932